Evidence map›Paper›PMID 38542508›Full record

ReviewInternational journal of molecular sciences2024

Noscapine and Apoptosis in Breast and Other Cancers.

Gloria M Calaf, Leodan A Crispin, Edwin O Quisbert-Valenzuela

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Design, Spectral Insights, and Enhanced Antioxidant Potential of Novel Phenothiazine DerivativesAnti-inflammatory & anti-allergy agents in medicinal chemistry · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gloria M CalafInstituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.
Leodan A CrispinInstituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.
Edwin O Quisbert-ValenzuelaInstituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.
University of Tarapacá · CL

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) FONDECYT 1200656 (GMC)Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) FONDECYT 1231537 (GMC)
6 · The paper itself

Abstract

Breast cancer is the second leading contributor to the age-standardized mortality rate, for both sexes and all ages worldwide. In Europe and the United States, it is the second leading cause of mortality, with an incidence rate of about 2.6 million cases per year. Noscapine, a well-known alkaloid used as a cough suppressant, demonstrated anti-tumor effects by triggering apoptosis in various cancer cell lines and has the potential to become another ally against breast, ovarian, colon, and gastric cancer, among other types of malignancy. Apoptosis plays a crucial role in the treatment of cancer. Noscapine affected

Indexed as

Antineoplastic AgentsBreast NeoplasmsGlioblastomaNoscapineApoptosisbcl-2-Associated X ProteinCell Line, TumorCell ProliferationFemaleHumansAntineoplastic Agentsbcl-2-Associated X ProteinNoscapineapoptosisBaxBcl-2breast cancercaspase-8caspase-9noscapine

Identifiers

PMID38542508
PMCPMC10970989
OpenAlexW4393047700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.